Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach

Journal of Hepatology

Volumn 52, Issue 6, 2010, Pages 889-894

  Shen, Ying Chun ^a,b   Hsu, Chiun ^b   Chen, Li Tzong ^c   Cheng, Chia Chi ^b   Hu, Fu Chang ^b   Cheng, Ann Lii ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Adjuvant therapy; Anti viral agents; Hepatocellular carcinoma; Meta analysis; Meta regression

Indexed keywords

INTERFERON; RECOMBINANT INTERFERON;

ABLATION THERAPY; ADJUVANT THERAPY; ANTIVIRAL THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; META ANALYSIS; MULTIPLE CANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; LIVER NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; REGRESSION ANALYSIS;

EID: 77952422635     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.12.041     Document Type: Article

References (34)

1. Bosch F.X., Ribes J., Díaz M., and Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 127 (2004) S5-S16
2. Altekruse S.F., McGlynn K.A., and Reichman M.E. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27 (2009) 1485-1491
3. Pawlik T.M., Esnaola N.F., and Vauthey J.N. Surgical resection of hepatocellular carcinoma: similar long-term results despite geographic variations. Liver Transpl 10 (2004) S74-S80
4. Llovet J.M., and Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48 (2008) S20-S37
5. Kao J.H., and Chen D.S. Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia. Liver Int 25 (2005) 696-703
6. Cammà C., Licata A., Cabibbo G., Latteri F., and Craxì A. Treatment of hepatitis C: critical appraisal of the evidence. Expert Opin Pharmacother 6 (2005) 399-408
7. Shamliyan T.A., MacDonald R., Shaukat A., Taylor B.C., Yuan J.M., Johnson J.R., et al. Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference. Ann Int Med 150 (2009) 111-124
8. Ikeda K., Arase Y., Saitoh S., Kobayashi M., Suzuki Y., Suzuki F., et al. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor - a prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 32 (2000) 228-232
9. Kubo S., Nishiguchi S., Hirohashi K., Tanaka H., Shuto T., Yamazaki O., et al. Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial. Ann Int Med 134 (2001) 963-967
10. Kubo S., Nishiguchi S., Hirohashi K., Tanaka H., Shuto T., and Kinoshita H. Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy. Brit J Surg 89 (2002) 418-422
11. Lin S.M., Lin C.J., Hsu C.W., Tai D.I., Sheen I.S., Lin D.Y., et al. Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors. Cancer 100 (2004) 376-382
12. Chen L.T., Chen M.F., Lee L.A., Lee P.H., Jeng L.B., Lin D.Y., et al. Randomized phase III study of adjuvant interferon alfa-2b in hepatocellular carcinoma with curative resection - the Taiwan Cooperative Oncology Group (TCOG T1297) study. Hepatology 42 (2005) 237A [Abs.]
13. Mazzaferro V., Romito R., Schiavo M., Mariani L., Camerini T., Bhoori S., et al. Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology 44 (2006) 1543-1554
14. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions 4.2.6 (updated September 2006). The Cochrane library. Chichester: John Wiley & Sons; 2006.
15. Whitehead A. Meta-analysis of controlled clinical trials (2002), John Wiley & Sons, New York
16. Hsu C., Shen Y.C., Cheng C.C., Hu F.C., and Cheng A.L. Geographic difference in survival outcome for advanced hepatocellular carcinoma: implications on future clinical trial design. Contemp Clin Trials (2009) [Epub ahead of print]
17. Suou T., Mitsuda A., Koda M., Matsuda H., Maruyama S., Tanaka H., et al. Interferon alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C: a pilot study. Hepatol Res 20 (2001) 301-311
18. Miyaguchi S., Watanabe T., Takahashi H., Nakamura M., Saito H., and Ishii H. Interferon therapy for hepatocellular carcinoma patients with low HCV-RNA levels. Hepatogastroenterology 49 (2002) 724-729
19. Shiratori Y., Shiina S., Teatani T., Imamura M., Obi S., Sato S., et al. Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus. Ann Int Med 138 (2003) 299-306
20. Sun H.C., Tang Z.Y., Wang L., Qin L.X., Ma Z.C., Ye Q.H., et al. Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial. J Cancer Res Clin Oncol 132 (2006) 458-465
21. Lo C.M., Liu C.L., Chan S.C., Lam C.M., Poon R.T., Ng I.O., et al. A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. Ann Surg 245 (2007) 831-842
22. Jeong S.C., Aikata H., Katamura Y., Azakami T., Kawaoka T., Saneto H., et al. Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma. World J Gastroenterol 13 (2007) 5343-5350
23. Jeong S., Aikata H., Katamura Y., Azakami T., Kawaoka T., Saneto H., et al. Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma. World J Gastroenterol 13 (2007) 5188-5195
24. Kudo M., Sakaguchi Y., Chung H., Hatanaka K., Hagiwara S., Ishikawa E., et al. Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study. Oncology 72 (2007) 132-138
25. Huang G.T., Lee P.H., Tsang Y.M., Lai M.Y., Yang P.M., Hu R.H., et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma a prospective study. Ann Surg 242 (2005) 36-42
26. Hasegawa K., Makuuchi M., Takayama T., Kokudo N., Arii S., Okazaki M., et al. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 49 (2008) 589-594
27. Llovet J.M., Di Bisceglie A.M., Bruix J., Kramer B.S., Lencioni R., Zhu A.X., et al. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100 (2008) 698-711
28. Hoshida Y., Villanueva A., Kobayashi M., Peix J., Chiang D.Y., Camargo A., et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 359 (2008) 1995-2004
29. Lok A.S.F., and McMahon B.J. Chronic hepatitis B. Hepatology 45 (2007) 507-539
30. Strader D.B., Wright T., Thomas D.L., and Seeff L.B. Diagnosis, management, and treatment of hepatitis C. Hepatology 39 (2004) 1147-1171
31. Yu M.L., Huang C.F., Dai C.Y., Huang J.F., and Chuang W.L. Long-term effects of interferon-based therapy for chronic hepatitis C. Oncology 72 (2007) 16-23
32. Yu M.L., Lin S.M., Chuang W.L., Dai C.Y., Wang J.H., Lu S.N., et al. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan. Antiviral Ther 11 (2007) 985-994
33. Breitenstein S., Dimitroulis D., Petrowsky H., Puhan M.A., Müllhaupt B., and Clavien P.A. Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis. Brit J Surg 96 (2009) 975-981
34. Petrowsky H., and Busuttil R.W. Resection or ablation of small hepatocellular carcinoma: what is the better treatment?. J Hepatol 49 (2008) 502-504